|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.730 USD | -0.63% |
|
+2.83% | +233.10% |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
| 08-13 | Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EDESA BIOTECH, INC. | Bio Therapeutic Drugs | -0.63% | +2.83% | +233.10% | +93.06% | -88.35% | 64.31M |  | |  |
- Stock Market
- Stocks
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
